Benzhydryl Compounds - Therapeutic use
Research News and Information

Monday, November 23, 2009

Armodafinil.

30 Aug 2009 Armodafinil is the R-enantiomer of modafinil, a wake-promoting agent, that primarily affects areas of the brain involved in controlling wakefulness. Once-daily armodafinil was effective in improving wakefulness in adult patients with excessive ... Read more...

Tolterodine extended-release for overactive bladder.

30 Aug 2009 Overactive bladder (OAB) is a common problem. Affected individuals suffer decreased quality of life and productivity. The mainstay of pharmacological treatment of OAB is antimuscarinic agents. Tolterodine was the first antimuscarinic drug designed ... Read more...

Double anticholinergic therapy for refractory overactive bladder.

18 Aug 2009 PURPOSE: Using 2 anticholinergic medications simultaneously (10 to 30 mg oxybutynin, 4 mg tolterodine and/or 5 to 10 mg solifenacin) we optimized the medical therapy for children in whom single agent anticholinergic therapy failed. We evaluated ... Read more...

Latest indexed articles for 'Benzhydryl Compounds - Therapeutic use'

These are the very latest articles for this heading:

• Disease mongering and excessive daytime sleepiness. 13 Oct 2009
• Armodafinil. 30 Aug 2009
• Tolterodine extended-release for overactive bladder. 30 Aug 2009
• Double anticholinergic therapy for refractory overactive bladder. 18 Aug 2009
• Editorial comment. 18 Aug 2009
• Editorial comment. 18 Aug 2009
• Editorial comment. 18 Aug 2009
• Effect of modafinil on subjective fatigue in multiple sclerosis and stroke patients. 5 Aug 2009
• GABA(B) receptors, schizophrenia and sleep dysfunction: a review of the relationship and its potential clinical and therapeutic implications. 30 Jul 2009
• Neuroimaging of narcolepsy. 30 Jul 2009
• Modafinil as a potential motion sickness countermeasure. 30 Jul 2009
• Randomized trial of percutaneous tibial nerve stimulation versus extended-release tolterodine: results from the overactive bladder innovative therapy trial. 16 Jul 2009
• [Combination of tolterodine and tamsulosin for benign prostatic hyperplasia] 29 Jun 2009
• Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate. 29 Jun 2009
• Modafinil for the treatment of cocaine dependence. 24 Jun 2009
• The effect of modafinil on cognitive function in breast cancer survivors. 13 Jun 2009
• A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder. 10 May 2009
• Fesoterodine (toviaz) for overactive bladder. 2 May 2009
• A pilot study evaluating the safety and efficacy of modafinal for cancer-related fatigue. 29 Apr 2009
• Narcolepsy--master of disguise: evidence-based recommendations for management. 29 Apr 2009

See a longer list of these articles.

Technical information about 'Benzhydryl Compounds'

Definition: Compounds which contain the methyl radical substituted with two benzene rings. Permitted are any substituents, but ring fusion to any of the benzene rings is not allowed.

Registry Number: 0

Descriptor UI: D001559

Alternative terms: Benzhydryl Compounds; Compounds, Benzhydryl; Diphenylmethyl Compounds; Compounds, Diphenylmethyl;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D02.455.426.559.389.115;

History Note: 75

Technical Notes: DF: BENZHYDRYL CPDS